Medial septal dysfunction by Aβ-induced KCNQ channel-block in glutamatergic neurons

Richardson N Leão1, Luis V Colom, Lotta Borgius

  • 1Neuronal Oscillations Laboratory, KI Alzheimer's Disease Research Center, NVS, Karolinska Institute, Stockholm, Sweden.

Neurobiology of Aging
|September 13, 2011
PubMed

Insights

Amyloid beta peptides disrupt brain rhythms in Alzheimer's disease by impairing glutamatergic neurons in the medial septum. This dysfunction affects neural network activity, potentially causing memory loss.

Area of Science:

  • Neuroscience
  • Cellular Biology
  • Pathophysiology

Background:

  • Alzheimer's disease (AD) involves amyloid beta (Aβ) peptides, but cellular toxicity mechanisms remain unclear.
  • Medial septum (MS) neurons are crucial for brain rhythm generation and memory formation.

Purpose of the Study:

  • To investigate the acute effects of Aβ peptides on different medial septum neuron classes.
  • To elucidate the cellular mechanisms of Aβ toxicity in the context of Alzheimer's disease.

Main Methods:

  • Electrophysiological recordings and calcium imaging in mouse medial septum neurons.
  • Application of Aβ(25-35) and Aβ(1-40) peptides.
  • Analysis of neuronal firing patterns and ion channel currents (I(A) and I(M)).

Main Results:

  • Aβ differentially affects glutamatergic and non-glutamatergic MS neurons.
  • Aβ specifically blocks the M-current (I(M)) in glutamatergic neurons, increasing their firing rate.
  • Aβ disrupts theta-frequency firing coherence in non-glutamatergic neurons.

Conclusions:

  • Aβ-induced M-current block in glutamatergic neurons impairs medial septum rhythmicity.
  • This disruption may negatively impact hippocampal function and contribute to memory deficits in Alzheimer's disease.